Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy

PURPOSE: The purpose of this study was to identify chemotherapy induced peripheral neuropathy, quality of life of patients with gynecologic cancer. METHODS: This was a cross-sectional survey design. We collected 130 patients with gynecologic cancer. They complete a self reported questionnaire includ...

Full description

Bibliographic Details
Main Authors:	Ju Hyeon Jeong, Ju Hee Nho, Gi Suk Kim, Young Eun Lee, Sun Young Yu, Hyun Ju Lee, Yu Mi Sim, Young Sun Lee
Format:	Article
Language:	English
Published:	Korean Society of Women Health Nursing 2013-12-01
Series:	Korean Journal of Women Health Nursing
Subjects:	gynecologic neoplasm chemotherapy induced peripheral neuropathy quality of life
Online Access:	http://www.kjwhn.org/upload/pdf/kjwhn-19-201.pdf

Similar Items

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2022-08-01)

Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2023-09-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Expression Profiles of Circulating MicroRNAs in XELOX-Chemotherapy-Induced Peripheral Neuropathy in Patients with Advanced Gastric Cancer
by: Yeongdon Ju, et al.
Published: (2022-05-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Comparison of Clinical Symptoms and Neurophysiological Findings in Patients With Chemotherapy Induced Peripheral Neuropathy
by: Kye Hee Cho, et al.
Published: (2022-06-01)

Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
by: Bojana Milutinovic, et al.
Published: (2022-07-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
by: Timothy F. Marshall, et al.
Published: (2017-12-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)

Relationships among Malnutrition, Depression and Quality of Life in Patients with Gynecologic Cancer receiving Chemotherapy
by: Ju Hee Nho, et al.
Published: (2014-06-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
by: Katarzyna Szklener, et al.
Published: (2022-01-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
by: Aparna Areti, et al.
Published: (2014-01-01)

Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy
by: Daisuke Kawata, et al.
Published: (2017-09-01)

The Efficacy of Neuromodulation Interventions for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
by: Xu R, et al.
Published: (2024-04-01)

Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine
by: Geehoon Chung, et al.
Published: (2022-07-01)

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01)

Chemotherapy induced peripheral neuropathic pain
by: Hue Jung Park
Published: (2014-07-01)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms
by: L. Brett Whalen, et al.
Published: (2022-02-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
by: Sonoko Misawa, et al.
Published: (2023-11-01)

Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
by: Jae-Gyeong Jeong, et al.
Published: (2023-01-01)

Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
by: S. Najafi, et al.
Published: (2021-11-01)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
by: Pasquale Sansone, et al.
Published: (2022-08-01)

Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial
by: Chien-Chen Huang, et al.
Published: (2021-08-01)

Assessment of Fall-Related Self-Efficacy: Characteristics that Influence the Perception of Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Sena Yamamoto, et al.
Published: (2020-01-01)